SCHEMBL651696

SCHEMBL651696

CCCCn1c(-c2ccncc2)nc(-c2ccc(OC)cc2)c1CC(NCc1ccc(N)c(O)c1)C1CCCCC1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 1/20 0.36
TEK Q02763 4/20 0.34
LMNA P02545 3/20 0.32
MAPT P10636 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MEN1 O00255 1/20 0.32
CRHBP P24387 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
CRHR2 Q13324 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CNR1 P21554 1/20 0.32
TP53 P04637 1/20 0.32
AVPR1B P47901 4/20 0.31
OXTR P30559 1/20 0.31
AVPR1A P37288 1/20 0.31
CCR5 P51681 2/20 0.31
PDE5A O76074 1/20 0.31
MDM2 Q00987 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL651697 0.81 PDE4B (0.37) PDE4BTEKLMNAMAPTALDH1A1
SCHEMBL4769324 0.78 C5AR1 (0.39) MAPTALDH1A1NPSR1TP53MDM2
SCHEMBL649268 0.75 ALDH1A1 (0.33) LMNAMAPTALDH1A1MEN1CRHBP
SCHEMBL4764000 0.72 ALDH1A1 (0.42) PDE4BMAPTALDH1A1MEN1KMT2A
SCHEMBL651698 0.72 NPC1 (0.36) PDE4BTEKLMNAMAPTALDH1A1
SCHEMBL648736 0.71 ATM (0.36) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL648898 0.70 LMNA (0.36) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL651425 0.69 MTNR1B (0.35) MAPTALDH1A1MEN1KMT2A
SCHEMBL10289127 0.68 BCHE (0.41) PDE4BLMNAALDH1A1MEN1KMT2A
SCHEMBL651079 0.68 AGTR1 (0.34) LMNAALDH1A1MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed